KMT2A-rearranged acute lymphoblastic leukaemia
KMT2A-rearranged acute lymphoblastic leukaemia (ALL) represents a high risk subtype of childhood ALL. Historical treatment strategies have comprised of intensification with conventional chemotherapy. However, outcomes have remained consistently poor compared to the advances that have been seen for o...
Saved in:
| Main Authors: | Rishi S. Kotecha, Rob Pieters, Janine Stutterheim |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | EJC Paediatric Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772610X24000643 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NG2 MOLECULE EXPRESSION IN ACUTE LYMPHOBLASTIC LEUKEMIA B CELLS: A FLOW-CYTOMETRIC MARKER FOR THE RAPID IDENTIFICATION OF KMT2A GENE REARRANGEMENTS
by: Maria Laura Bisegna, et al.
Published: (2024-02-01) -
Loss of SMAD1 in acute myeloid leukemia with KMT2A::AFF1 and KMT2A::MLLT3 fusion genes
by: Lisa Dietsche, et al.
Published: (2025-01-01) -
Lineage switch in relapse of acute leukemia with rearrangement of MLL gene (KMT2A). literature review and case reports
by: E. A. Zerkalenkova, et al.
Published: (2016-08-01) -
Lactylation modulation identifies key biomarkers and therapeutic targets in KMT2A-rearranged AML
by: Dan Liu, et al.
Published: (2025-01-01) -
Acute B-cell lymphoblastic leukaemia presenting as acute hepatitis
by: I. Jenosha, et al.
Published: (2025-03-01)